<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Daly Crowley | Activity</title>
	<link>https://www.catswannabecats.com/members/ghanaocelot4/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/ghanaocelot4/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Daly Crowley.</description>
	<lastBuildDate>Tue, 30 Jun 2026 07:59:13 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">df4ebe602e7ce3bc79ba695ee77b17ae</guid>
				<title>Daly Crowley posted an update: Pseudoprogression and hyperprogression are new radiologic [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/23493/</link>
				<pubDate>Sun, 08 Jun 2025 09:20:02 -0400</pubDate>

									<content:encoded><![CDATA[<p>Pseudoprogression and hyperprogression are new radiologic response patterns with immunotherapy agents. It is critical to be aware of these two phenomena in order to make the right decisions for patients.Previous research into predictive inferences making showed that textual constraint influenced hemispheric processing of the inferences. However,&hellip;<span class="activity-read-more" id="activity-read-more-23493"><a href="https://www.catswannabecats.com/activity/p/23493/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">9bddac5180708ee58197bb965de5de7d</guid>
				<title>Daly Crowley posted an update: We find that the tetrapeptide GluGluLeuGlu binds to one of [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/17765/</link>
				<pubDate>Tue, 03 Jun 2025 09:09:36 -0400</pubDate>

									<content:encoded><![CDATA[<p>We find that the tetrapeptide GluGluLeuGlu binds to one of the three polybasic cleavage sites of the SARS-CoV-2 spike protein lessening by 34% the RBD-ACE2 binding strength. This significant binding energy reduction demonstrates the feasibility to neutralize RBD-ACE2 binding by targeting this specific polybasic cleavage site. Our work enhances&hellip;<span class="activity-read-more" id="activity-read-more-17765"><a href="https://www.catswannabecats.com/activity/p/17765/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">13cbd85b1e1ece12bd85822486e14d45</guid>
				<title>Daly Crowley posted an update: Lung cancer is the leading cause of cancer-related deaths [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/7792/</link>
				<pubDate>Sat, 31 May 2025 19:59:14 -0400</pubDate>

									<content:encoded><![CDATA[<p>Lung cancer is the leading cause of cancer-related deaths worldwide. The paralogous transcriptional cofactors Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ, also called WWTR1), the main downstream effectors of the Hippo signal transduction pathway, are emerging as pivotal determinants of malignancy in&hellip;<span class="activity-read-more" id="activity-read-more-7792"><a href="https://www.catswannabecats.com/activity/p/7792/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d8827f7dc5faf9eea4d75da331431181</guid>
				<title>Daly Crowley became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/7020/</link>
				<pubDate>Sat, 31 May 2025 17:43:50 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>